J&J Medical Connect
DARZALEX FASPRO®

(daratumumab and hyaluronidase-fihj)

This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.

DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)

Patient Medical Information

Does DARZALEX FASPRO Contain Latex?

Last Updated: 06/27/2024

summary

  • DARZALEX FASPRO does not contain latex.1
    • The immediate container does not contain latex/natural rubber. However, it cannot be guaranteed that the immediate container has not come in contact with latex during the manufacturing or packaging process (eg, latex gloves).1
    • The materials do not contain latex as an ingredient. However, it cannot be guaranteed that the materials have not come in contact with latex during the manufacturing or packaging process (eg, latex gloves). There is no information on latex (natural rubber) for rHuPH20 (hyaluronidase).1
  • The following content from the DARZALEX FASPRO MEDICATION GUIDE may be helpful to address your question:

What are the ingredients in DARZALEX FASPRO?

  • Active ingredients: Daratumumab and hyaluronidase-fihj2
  • Inactive ingredients: L-histidine, L-histidine hydrochloride monohydrate, L-methionine, polysorbate 20, sorbitol, and water for injection2

additional information

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION and the PATIENT MEDICATION GUIDE for DARZALEX FASPRO.2

 

References

1 Data on File. Technical Document Patient Safety and Compliance Information. Janssen Research & Development, LLC. TV-TEC-172936; 2021.  
2 DARZALEX FASPRO (daratumumab and hyaluronidase) [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc.; https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/DARZALEX+Faspro-pi.pdf.